Achieve Life Sciences Inc (ACHV) — Cash Flow-to-Debt Ratio
Achieve Life Sciences Inc (ACHV) has a Cash Flow-to-Debt Ratio of -0.31x as of March 2026, meaning its operating cash flow of $-6.93 Million could theoretically repay 0% of its total liabilities ($22.43 Million) in one year. Check Achieve Life Sciences Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Achieve Life Sciences Inc Cash Flow-to-Debt Ratio (1994–2025)
Historical debt coverage capacity for Achieve Life Sciences Inc across 32 annual periods. Also explore ACHV current and non-current assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Achieve Life Sciences Inc (1994–2025)
Year-by-year debt coverage analysis for Achieve Life Sciences Inc. For market capitalisation and broader financial context, see Achieve Life Sciences Inc (ACHV) market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.44x | $-49.47 Million | $20.27 Million | ▼ -45.4% |
| 2024 | -1.68x | $-29.77 Million | $17.73 Million | ▼ -42.8% |
| 2023 | -1.18x | $-24.48 Million | $20.82 Million | ▲ +32.2% |
| 2022 | -1.73x | $-37.57 Million | $21.67 Million | ▼ -14.7% |
| 2021 | -1.51x | $-29.44 Million | $19.47 Million | ▲ +66.2% |
| 2020 | -4.47x | $-13.47 Million | $3.01 Million | ▲ +11.0% |
| 2019 | -5.03x | $-15.22 Million | $3.03 Million | ▼ -55.3% |
| 2018 | -3.24x | $-10.62 Million | $3.28 Million | ▲ +28.5% |
| 2017 | -4.52x | $-9.11 Million | $2.01 Million | ▼ -29.6% |
| 2016 | -3.49x | $-29.68 Million | $8.50 Million | ▼ -696.5% |
| 2015 | -0.44x | $-9.10 Million | $20.77 Million | ▲ +43.7% |
| 2014 | -0.78x | $-17.31 Million | $22.23 Million | ▲ +60.0% |
| 2013 | -1.94x | $-35.93 Million | $18.48 Million | ▲ +29.3% |
| 2012 | -2.75x | $-43.49 Million | $15.81 Million | ▼ -404.1% |
| 2011 | -0.55x | $-20.26 Million | $37.12 Million | ▲ +6.9% |
| 2010 | -0.59x | $-26.84 Million | $45.79 Million | ▼ -177.3% |
| 2009 | 0.76x | $34.88 Million | $46.02 Million | ▲ +125.1% |
| 2008 | -3.01x | $-12.31 Million | $4.08 Million | ▼ -72.4% |
| 2007 | -1.75x | $-23.34 Million | $13.34 Million | ▼ -126.1% |
| 2006 | -0.77x | $-19.68 Million | $25.45 Million | ▼ -109.5% |
| 2005 | -0.37x | $-8.36 Million | $22.65 Million | ▲ +91.2% |
| 2004 | -4.19x | $-14.62 Million | $3.49 Million | ▲ +8.8% |
| 2003 | -4.59x | $-9.91 Million | $2.16 Million | ▲ +2.4% |
| 2002 | -4.70x | $-10.40 Million | $2.21 Million | ▼ -551.4% |
| 2001 | 1.04x | $1.25 Million | $1.20 Million | ▲ +252.1% |
| 2000 | -0.69x | $-3.97 Million | $5.80 Million | ▼ -5449.7% |
| 1999 | -0.01x | $-100.00K | $8.10 Million | ▲ +98.6% |
| 1998 | -0.91x | $-10.30 Million | $11.30 Million | ▼ -777.1% |
| 1997 | 0.13x | $1.40 Million | $10.40 Million | ▼ -61.5% |
| 1996 | 0.35x | $3.50 Million | $10.00 Million | ▲ +139.0% |
| 1995 | -0.90x | $-7.80 Million | $8.70 Million | ▼ -212.5% |
| 1994 | -0.29x | $-3.50 Million | $12.20 Million | — |